Identification of an α(1→6) mannopyranosyltransferase (MptA), involved in Corynebacterium glutamicum lipomanann biosynthesis, and identification of its orthologue in Mycobacterium tuberculosis by Mishra, Arun K et al.
Identiﬁcation of an a(1,6) mannopyranosyltransferase
(MptA), involved in Corynebacterium glutamicum
lipomanann biosynthesis, and identiﬁcation of its
orthologue in Mycobacterium tuberculosis
OnlineOpen: This article is available free online at www.blackwell-synergy.com                             
Arun K. Mishra,1† Luke J. Alderwick,1†
Doris Rittmann,2† Raju V. V. Tatituri,1 Jerome Nigou,3
Martine Gilleron,3 Lothar Eggeling2 and
Gurdyal S. Besra1*
1School of Biosciences, University of Birmingham,
Edgbaston, Birmingham B15 2TT, UK.
2Institute for Biotechnology 1, Research Centre Juelich,
D-52425 Juelich, Germany.
3Institute de Parmacologie et de Biologie Structurale,
UMR CNRS 5089, Toulouse, France.
Summary
Corynebacterium glutamicum and Mycobacterium
tuberculosis share a similar cell wall architecture, and
the availability of their genome sequences has
enabled the utilization of C. glutamicum as a model
for the identiﬁcation and study of, otherwise essen-
tial, mycobacterial genes involved in lipomannan (LM)
and lipoarabinomannan (LAM) biosynthesis. We
selected the putative glycosyltransferase-Rv2174
from M. tuberculosis and deleted its orthologue
NCgl2093 from C. glutamicum. This resulted in the
formation of a novel truncated lipomannan (Cg-t-LM)
and a complete ablation of LM/LAM biosynthesis.
Puriﬁcation and characterization of Cg-t-LM revealed
an overall decrease in molecular mass, a reduction of
a(1,6) and a(1,2) glycosidic linkages illustrating a
reduced degree of branching compared with wild-
type LM. The deletion mutant’s biochemical pheno-
type was fully complemented by either NCgl2093
or Rv2174. Furthermore, the use of a synthetic
neoglycolipid acceptor in an in vitro cell-free assay
utilizing the sugar donor b-D-mannopyranosyl-
1-monophosphoryl-decaprenol together with the
neoglycolipid acceptor a-D-Manp-(1,6)-a-D-Manp-
O-C8 as a substrate, conﬁrmed NCgl2093 and Rv2174
as an a(1,6) mannopyranosyltransferase (MptA),
involved in the latter stages of the biosynthesis of
the a(1,6) mannan core of LM. Altogether, these
studies have identiﬁed a new mannosyltransferase,
MptA, and they shed further light on the biosynthesis
of LM/LAM in Corynebacterianeae.
Introduction
The human pathogen and aetiological agent of tubercu-
losis, Mycobacterium tuberculosis, belongs to the distinct
and unusual group of the Corynebacterianeae, which
includes other human pathogens, such as Mycobacterium
leprae and Corynebacterium diphtheriae, the causal
agents of leprosy and diphtheria respectively (Coyle and
Lipsky, 1990; Bloom and Murray, 1992). Furthermore,
non-pathogenic bacteria also belong to this taxon, such
as Corynebacterium glutamicum, which is used in the
industrial production of amino acids (Stackebrandt et al.,
1997; Sahm et al., 2000).
The unique cell wall ultrastructure that is common
among these bacilli is composed of a mycolyl-
arabinogalactan–peptidoglycan (mAGP) complex (Daffe
et al., 1990; McNeil et al., 1990; 1991; Besra et al., 1995;
Brennan, 2003; Dover et al., 2004). Moreover, the
packing and ordering of mycolic acids and additional lipids
within the outer envelope results in a highly impermeable
barrier characteristic of this genera (Minnikin et al., 2002).
Other cell wall-associated lipids, such as phosphatidyl-
myo-inositol (PI) mannosides (PIMs) and lipoglycans,
termed lipomannan (LM) and lipoarabinomannan (LAM),
are also found in the outer leaﬂet of the cell wall (Hill
and Ballou, 1966; Brennan and Ballou, 1967; 1968;
Brennan and Nikaido, 1995; Besra et al., 1997; Morita
et al., 2004). In addition to their physiological function and
potential as drug targets, these glycoconjugates also play
a key role in the modulation of the host response during
infection (Schlesinger et al., 1994; Chatterjee and Khoo,
1998; Maeda et al., 2003; Nigou et al., 2002).
The current paradigm of mycobacterial lipoglycan
biosynthesis follows a linear pathway, PI → PIM → LM
→ LAM (Besra and Brennan, 1997), with each individual
step synthesizing an increasingly glycosylated molecule
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cosyltransferases (Fig. 1). PI acts as a substrate for the
a-mannosyltransferasePimA(Rv2610c),whichtransfersa
mannopyranosyl (Manp) residue from GDP-Mannose
to the 2-position of PI to form PIM1 (Kordulakova et al.,
2002). The second mannosylation step catalysed by
PimB(Rv0557)mayoccurbefore,orafteracylationofPIM1
by Rv2611c (Kordulakova et al., 2003), and results in the
formation of Ac1PIM2 (Schaeffer et al., 1999). We have
previously shown that PimB was also directly involved in
synthesizing a novel mannosylated glycolipid, 1,2-di-O-
C16/C18:1-(a-D-mannopyranosyl)-(1→4)-(a-D-glucopyran-
osyluronicacid)-(1→3)-glycerol(ManGlcAGroAc2)(Tatituri
et al., 2007), which is indicative of a more complex biosyn-
thetic pathway than previously considered. A third Manp
residue is added by PimC to form Ac1PIM3 (Kremer et al.,
2002). Recently, PimE (Rv1159) has been implicated in
higher PIM biosynthesis and the synthesis of Ac1PIM5
(Morita et al., 2006); however, the enzyme responsible for
the synthesis of the intermediate Ac1PIM4, from Ac1PIM3,
remains elusive. Indeed, Ac1PIM4 is the likely precursor to
LM formation (Morita et al., 2006). It has been proposed
that at this point, a transition occurs from glycosyltrans-
ferases,utilizingnucleotide-derivedsugarsubstrateschar-
acterized by the GT-A/B superfamily (Liu and Mushegian,
2003), to glycosyltransferases utilizing polyprenyl-
phosphate sugars and the GT-C superfamily (Liu and
Mushegian, 2003), for the elongation and branching of LM
and LAM (Morita et al., 2006). More recently, Rv2181 has
been reported to be involved in the synthesis of the
a(1→2)-Manp-linked branches, characteristic of the
mannan backbone in LM and LAM (Kaur et al., 2006).
However,theenzymerequiredforthesynthesisofthecore
linear LM/LAM mannan domain through an a(1→6) man-
nosyltransferase remains to be identiﬁed. The mature LM
is then further glycosylated by the essential arabinofura-
nosyltransferase EmbC (G.S. Besra, unpubl. results), to
form LAM (Berg et al., 2005), and recently a novel manno-
syltransferase, MT1671, has been shown to add terminal
Manp residues to the mature LAM in M. tuberculosis
CDC1551 to form ManLAM (Dinadayala et al., 2006).
Comparative analyses of LAMs from various strains of
mycobacteria have shown that, apart from the common
core structure, various levels of ‘capping’ exists at the
non-reducing terminus of the arabinan domain, in the form
of AraLAM, ManLAM and PILAM (Chatterjee et al., 1993;
Khoo et al., 1995; Guerardel et al., 2002).The presence or
absence of terminal Man or insoitol (Ins) residues has
emerged as the focal point for the current paradigm of
immunomodulation (Nigou et al., 2002; 2003). ManLAMs
have the capacity to inhibit the production of pro-
inﬂammatory cytokines, such as IL-12 and TNF-a
(Knutson et al., 1998; Nigou et al., 2002), whereas PILAM
has the ability to inhibit the proliferation of these cytokines
(Adams et al., 1993; Gilleron et al., 1997). Slow-growing
mycobacteria, such as M. tuberculosis and M. leprae,
exhibit a ManLAM phenotype and are able to exist and
replicate within phagocytic cells. However, faster-growing
strains such as Mycobacterium smegmatis, do not, which
illustrates the importance of ManLAM as a key virulence
factor (Nigou et al., 2002; 2003).
Apart from C. glutamicum and M. tuberculosis sharing a
similar cell wall architecture, the availability of completed
genome sequences for both organisms has enabled us to
use C. glutamicum as a suitable model for the identiﬁca-
tion and functional study of mycobacterial genes involved
in arabinogalactan and LAM biosynthesis (Gibson et al.,
2003; Gande et al., 2004; Alderwick et al., 2005; 2006;
Seidel et al., 2007a). In this article, we have examined
one such open reading frame (ORF) from C. glutamicum
NCgl2093, which encodes a putative GT-C glycosyltrans-
ferase on the basis of sequence similarity and homology
alignment using C. glutamicum as a model to identify the
key a(1→6) mannosyltransferase involved in LM biosyn-
thesis and a potential new drug target.
Fig. 1. Proposed glycolipid biosynthetic pathway leading to LAM
via LM and PIMs. ManT, mannosyltransferase; AraT,
arabinosyltransferase; PPM, polyprenyl-1-monophosphoryl-
mannose; DPA, decaprenyl-1-monophosphoryl-arabinose.
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Genome comparison of the NCgl2093/Rv2174 locus
In order to advance further our understanding of glycosyl-
transferases in Corynebacterianeae, we focused on the
genes annotated by NCgl2093 (1527 bp) and Rv2174
(1548 bp) from C. glutamicum and M. tuberculosis,
respectively,whicharerecognizedasglycosyltransferases
of unknown function (Liu and Mushegian, 2003).As shown
in Fig. 2A the genomic organization of these genes in all
Corynebacterianeae analysed is syntenic, and even in
M. leprae the locus organization is retained, indicating an
apparentfundamentalfunctionofitsproduct.Apfamanaly-
sis (Bateman et al., 2004) of the ORF upstream of Rv2174
revealed that the gene product derived bears structural
similaritiestopolyprenylsynthetases,whichcouldbefunc-
tionally related to the glycosyltransferase, and both genes
might form a transcriptional unit.
In C. glutamicum and M. tuberculosis, a number of
orthologous GT-C family glycosyltransferases have been
identiﬁed by us and others, which transverse the mem-
brane (Alderwick et al., 2006; Kaur et al., 2006; Morita
et al., 2006; Seidel et al., 2007a, b). Indeed, NCgl2093
and its M. tuberculosis orthologue (Rv2174) are putative
membrane-bound GT-C glycosyltransferases (Fig. 2B).
Although, both orthologues have 13 transmembrane-
spanning helices (TMHs), they differ from the
Fig. 2. Comparison of the mptA locus within the
Corynebacterianeae and in-frame deletion of Cg-mptA.
A. The locus in the bacteria analysed consists of mptA which in
C. glutamicum has the locus tag NCgl2093 and in M. tuberculosis
Rv2174. Upstream of mptA, an ORF is conserved which could form
together with mptA a transcriptional unit, and which is predicted to
encode a polyprenyl synthetase. The genomic region displayed
encompasses 6 kb, and orthologous genes are highlighted
accordingly.
B. MptA spans the membrane 13 times and a large loop connects
TMH 3 and 4. Part of the loop sequence is given, where acid and
basic residues are highlighted. On top of the sequence comparison
the predicted secondary structure is given, with H indicating a
helical structure, and L a loop region. The entire region has a high
solvent accessibility, which indicates together with the conserved
aspartyl residues their functional signiﬁcance. M. bov.,
Mycobacterium bovis; M. tub. Mycobacterium tuberculosis; M. lep.,
Mycobacterium leprae; M. par., Mycobacterium paratuberculosis;
M. avi., Mycobacterium avium; M. sme., Mycobacterium smegmatis;
R. spe., Rhodococcus sp. (strain RHA1); C. glu., Corynebacterium
glutamicum; C. dip., Corynebacterium diphtheriae.
C. Strategy to delete Cg-mptA using the deletion vector
pK19mobsacBDmptA. This vector carries 18 nucleotides of the 5′
end of Cg-mptA and 36 nucleotides of its 3′ end thereby enabling
the in-frame deletion of almost the entire Cg-mptA gene. The
arrows marked P1 and P4 locate the primers used for the PCR
analysis to conﬁrm the absence of Cg-mptA. Distances are not
drawn to scale. The results of the PCR analysis with the primer
pair P1/P4 are shown on the right. Ampliﬁcation products obtained
from the wild type (wt) were applied in the left lane and that of the
deletion mutant (D) in the right lane. ‘St’ marks the standard, where
the arrowheads located at 1.5, 1 and 0.5 kb.
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mannose capping of LAM (Dinadayala et al., 2006) and
the arabinofuranosyltransferases AftA, AftB and the Emb
proteins (Alderwick et al., 2005; 2006; Seidel et al.,
2007a,b), by the absence of a periplasmatic extension at
the carboxy-terminus (Fig. 2B). The degree of conserva-
tion, with respect to topology and sequence among
the orthologues of NCgl2093, is high within the
Corynebacterianeae. For instance, the similarity of the
C. glutamicum and M. tuberculosis protein is 58%, and
with the most distant pairs among the Corynebacterium
species, C. glutamicum and C. jeikeium, the similarity is
approximately 64%. One of the most conserved regions is
between TMH 3 and 4. This long loop region is schemati-
cally shown in Fig. 2B, as is part of its sequence. This
sequence is reminiscent to the glycosyltransferase family
GT-C-modiﬁed DXD motif, as it contains a number of
basic and acidic residues, the latter shown in mutational
studies to be essential for glycosyl transfer from polypre-
nylated phospho-sugar donors (Berg et al., 2005; Seidel
et al., 2007b). Based on the results described below, the
Rv2174 gene and its orthologues was designated mptA
(acronym for mannopyranosyltransferase A).
Construction and growth of C. glutamicumDmptA
In an attempt to delete mptA in C. glutamicum, the non-
replicative plasmid pK19mobsacBDmptA was constructed
carrying sequences adjacent to Cg-mptA. The vector was
introduced into C. glutamicum and in several electropora-
tion assays kanamycin-resistant clones were obtained,
indicating integration of the vector into the genome by
homologous recombination (Fig. 2C). The sacB gene
enables for positive selection of a second homologous
recombination event, which can result either in the original
wild-type genomic organization or in clones deleted of
mptA. Twenty-four clones exhibiting the desired pheno-
type of vector-loss (KanS, SucR) were analysed by PCR
and 18 of them were found to have Cg-mptA excised.
These numbers indicate that the loss of Cg-mptA is
apparently not a disadvantage for viability.As a result, one
clone was subsequently termed C. glutamicumDmptA and
conﬁrmed by PCR to have Cg-mptA deleted, whereas
controls with C. glutamicum wild type resulted in the
expected larger ampliﬁcation product (Fig. 2C).
Growth of wild-type C. glutamicum and C. gluta-
micumDmptA were compared in brain–heart infusion
(BHI) medium as well as salt medium CGXII (Eggeling
and Bott, 2005). Both strains exhibited comparable
growth rates and ﬁnal cell densities grown on CGXII of
0.31  0.2 h-1 and 29.4  2.3 (OD600) for the two strains
respectively. Thus, C. glutamicumDmptA does not ex-
hibit an apparent growth defect under the conditions
assayed indicating a degree of tolerance to the deletion of
Cg-mptA. C. glutamicumDmptA was transformed with
pVWEx-Mt-mptA and pVWEx-Cg-mptA. As expected with
these complemented strains, no alteration in growth phe-
notype was apparent (Fig. S1).
Chemical analysis of extracted lipoglycans
Extracted lipoglycans from C. glutamicum, C. gluta-
micumDmptA, C. glutamicumDmptA pVWEx-Cg-mptA
and C. glutamicumDmptA pVWEx-Mt-mptA were exam-
ined on 15% SDS-PAGE (Fig. 3). Extracts from wild-type
C. glutamicum showed the presence of Cg-LAM and
Cg-LM, while both of these lipoglycans were absent from
C. glutamicumDmptA (Fig. 3). Interestingly, a lower-
molecular-weight lipoglycan, now termed truncated (t)-LM
(Fig. 3), could be observed in C. glutamicumDmptA. Com-
plementation of C. glutamicumDmptA by either pVWEx-
Cg-mptA or pVWEx-Mt-mptA restored the wild-type
phenotype.
Cg-t-LM was puriﬁed by hydrophobic interaction chro-
matography (HIC) and compared with wild-type LM. Total
sugar analysis of alditol aceteate derived sugars from
Cg-t-LM by gas chromatography (GC), identiﬁed the pres-
ence of only mannose and traces of inositol (Fig. S2).
Glycosyl linkage analysis of the per-O-methylated alditol
acetate derivatives from Cg-t-LM indicated the presence
of t-Manp, 2-Manp, 6M a n p and 2,6-Manp, similar to wild-
type LM (Fig. 4A), but with an overall decrease in 6-Manp
and 2,6-Manp linkages, with respect to 2-Manp residues
(Fig. 4B). Overall, the SDS-PAGE and relative shift in
glycosyl linkage analysis of Cg-t-LM illustrates that dele-
Fig. 3. Lipoglycan proﬁles of C. glutamicum, C. glutamicumDmptA,
C. glutamicumDmptA pVWEx-Cg-mptA and C. glutamicumDmptA
pVWEx-Mt-mptA. Lipoglycans were analysed using SDS-PAGE and
visualized using a Pro-Q emerald glycoprotein stain (Invitrogen)
speciﬁc for carbohydrates. The three major bands represented by
Cg-LAM, Cg-LM and Cg-t-LM are indicated. The STD lane contains
CandyCane glycoprotein molecular weight standards (Invitrogen).
The four major bands represent glycoproteins of 180, 82, 42 and
18 kDa respectively.
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sesses a shorter mannan core and a reduced degree of
branching compared with Cg-LM (Fig. 6E). This would
tentatively suggest that NCgl2093 is probably involved in
the synthesis of the a(1→6) mannan core via an a(1→6)
mannosyltransferase, whereby deletion results in a
shorter backbone and in turn branching sites. Further-
more, the analysis of Cg-t-LM in comparison with Cg-LM
also suggests that the distal end to the PI of LM is prob-
ably more heavily branched (see Fig. 6E). This phenotype
is in contrast to studies of Rv2181 (Kaur et al., 2006),
whereby inactivation resulted in the complete loss of
2-Manp residues and a mut-LAM structure possessing a
linear a(1→6) mannan core devoid of a(1→2)-Manp
branches and as a result the characterization of Rv2181
as an a(1→2) mannosyltransferase involved in the earlier
stages of LM biosynthesis (see Fig. 7).
The extracted LM from C. glutamicum and
C. glutamicumDmptA were analysed by matrix-assisted
laser desorption ionization time of ﬂight mass spectrom-
etry (MALDI-TOF-MS). The negative MALDI-TOF-MS
spectrum of Cg-LM showed a broad unresolved peak
centred at m/z 5700 (Fig. 5A), indicating a molecular
mass of approximately 5.7 kDa for the major molecular
species of this lipoglycan. Analysis of Cg-t-LM from
C. glutamicumDmptA (Fig. 5B) produced a lower
average molecular mass of approximately 3.3 kDa, pro-
posing a composition based on extension of Ac1PIM2
(m/z 1398) (Tatituri et al., 2007) to afford Cg-t-LM as an
average molecule centred on Ac1PIM14. As highlighted in
our previous studies, the carbohydrate backbone of
Cg-LM has been shown to be composed of an
a(1→6)Manp backbone substituted at most of the O-2
positions by t-Manp and t-Manp-a-D-(1→2)-Manp units
(Tatituri et al., 2007). The different nuclear magnetic
resonance (NMR) spin systems of Cg-LM and Cg-t-LM
were further characterized by 1D 1H and 2D 1H-13C Het-
eronuclear Multiple Quantum Correlation (HMQC) NMR
(Fig. 6A–D). The Cg-t-LM from C. glutamicumDmptA
possessed the same spin systems (Fig. 6C and D) as
Cg-LM (Fig. 6A and B) and their anomeric resonances
were attributed as follows: dH1C1 5.12/101.2 (I1) to 2,6-
Manp, 5.05/105.2 (II1)t ot-Manp, 5.00/104.9 (III1)t o
2-Manp and 4.92/102.6 (VII1) to 6-Manp units respec-
tively. The intensity of 6-Manp unit resonances is very
faint in Cg-LM 1D 1H-NMR spectrum (Fig. 6A) and was
found to be much more intense in Cg-t-LM (Fig. 6C),
allowing for the observation of a 1H-13C-NMR cross-peak
at 4.92/102.6 on the HMQC NMR spectrum (Fig. 6D).
Indeed, supporting our earlier glycosyl linkage analysis,
integration of the 1D 1H-NMR resonances (2,6-Manp + t-
Manp/6-Manp: 7/1 for Cg-LM and 2/1 for Cg-t-LM) indi-
cated a reduced branching degree, approximately 50%
for Cg-t-LM, as compared with 78% for Cg-LM. Alto-
gether, the data indicate that Cg-t-LM in C. glutamicum-
DmptA occurs possibly as a result of inactivation of a
core a(1→6) mannosyltransferase, presumably involved
in assembly of the distal portion of Cg-LM, thereby ren-
dering a substrate possessing reduced sites for branch-
ing (Fig. 6E).
Fig. 4. Glycosyl linkage analysis of LM from C. glutamicum and Cg-t-LM from C. glutamicumDmptA. Per-O-methylated samples were
hydrolysed using 2 M triﬂuoroacetic acid, reduced and per-O-acetylated. The resulting partially per-O-methylated, per-O-acetylated alditol
acetates from C. glutamicum LM (A) and C. glutamicumDmptA Cg-t-LM (B) were analysed by GC/MS (Tatituri et al., 2007).
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Initial attempts to develop an in vitro assay using either
puriﬁed recombinant expressed Mt-MptA, Cg-MptA, or
Escherichia coli membranes expressing the said proteins,
have thus far proved unsuccessful. In an alternative
approach, we assessed the capacity of membrane
preparations from C. glutamicum, C. glutamicumDmptA,
C. glutamicumDmptA pVWEx-Cg-mptA and C. gluta-
micumDmptA pVWEx-Mt-mptA to catalyse a(1→6)
mannosyltransferase activity in a previously deﬁned
neoglycolipid acceptor assay utilizing an exogenous
a-D-Manp-(1→6)-a-D-Manp-O-C8 acceptor and b-D-C50
polyprenyl-1-monophosphoryl-[14C]mannose (PP[14C]M)
as a sugar donor (Brown et al., 2001) (Fig. 7A). Thin-layer
chromatographic (TLC) analysis of radiolabelled prod-
ucts, when assayed with C. glutamicum membranes,
resulted in the formation of two products, X and Y
(Fig. 7A and B). Control assays when performed in the
absence of acceptor afforded background counts, typi-
cally < 100 cpm per assay (Brown et al., 2001). The enzy-
matic synthesis of product X and Y using membranes
from C. glutamicum relates to the biosynthesis of the
radiolabelled trisaccharide a-D-[14C]Manp-(1→6)-a-D-
Manp-(1→6)-a-D-Manp-O-C8 (97 864 cpm) and the
tetrasaccharide a-D-[14C]Manp-(1→6)-a-D-[14C]Manp-
(1→6)-a-D-Manp-(1→6)-a-D-Manp-O-C8 (5915 cpm),
respectively, and is consistent with our previous
studies (Brown et al., 2001). However, when assays
were performed using membranes prepared from
C. glutamicumDmptA, a drastically reduced amount of
product X (1385 cpm) could be observed and a complete
absence of product Y, indicating that Cg-MptA provides
the majority of a(1→6) mannopyranosyltransferase activ-
ity utilizing the a-D-Manp-(1→6)-a-D-Manp-O-C8 neogly-
colipid acceptor. In addition, these results also suggest
the existence of a second a(1→6) mannopyranosyltrans-
ferase presumably affording the weak activity seen within
the membrane preparations of C. glutamicumDmptA and
involved in the synthesis of the a(1→6) mannan core
proximal to the PI of LM. Membranes assayed with
C. glutamicumDmptA complemented with either pVWEx-
Cg-mptA (X, 62 953 cpm; Y, 1947 cpm) or pVWEx-Mt-
mptA (X, 26 145 cpm; Y, 1174 cpm) restored product
formation to that of wild-type C. glutamicum, albeit at a
lower rate of transfer.
Fig. 5. MALDI-TOF-MS spectra of LM from
C. glutamicum (A) and Cg-t-LM from
C. glutamicum DmptA (B). MALDI-TOF-MS
spectra were acquired in the linear negative
mode with delayed extraction using
2,5-dihydrobenzoic acid as a matrix.
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Apart form belonging to the supragenic taxon Coryne-
bacterianeae, M. tuberculosis and C. glutamicum share
common cell wall features and biosynthetic machinery.
Many of the genes involved in M. tuberculosis cell wall
and cell wall lipid biosynthesis have been shown to be
essential for the growth, survival and pathogenicity of the
bacillus (Belisle et al., 1997; Mills et al., 2004; Mova-
hedzadeh et al., 2004; Bhatt et al., 2005). Due to the
essentiality of such genes in mycobacteria (Sassetti
et al., 2003), we have previously demonstrated the inher-
Fig. 6. A–D. Structural characterization of LM from C. glutamicum (A and B) and Cg-t-LM from C. glutamicumDmptA (C and D). 1D
1H
(A and C) and 2D
1H-
13C HMQC (B and D) NMR spectra of Cg-LMs in D2O at 313K. Expanded regions (d
1H: 4.80–5.25) (A and C) and
(d
1H: 4.80–5.25, d
13C: 99–107) (B and D) are shown. Glycosyl residues are labelled in roman numerals and their carbons and protons
in Arabic numerals. I, 2,6-a-Manp; II, t-a-Manp; III, 2-a-Manp;I V ,6 - a-Manp.
E. Structural representation of Cg-LM and Cg-t-LM. Cg-LM contains an a(1→6)-Manp backbone almost completely substituted by t-Manp,
t-Manp(1→2)-Manp units. Cg-t-LM contains a shorter a(1→6)-Manp backbone and a reduced degree of branching.
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genes involved in indispensable biochemical pathways
(Gande et al., 2004; Alderwick et al., 2005; 2006; Seidel
et al., 2007a). Akin to Corynebacterianeae arabino-
galactan biosynthesis, lipoglycan assembly is equally
complex, involving many enzymes catalysing glycosyl
transfer reactions producing large heterogeneous
polysaccharides, in the form of LM and LAM (Nigou
et al., 2003). The current model of LM/LAM biosynthesis
involves several GT-A/B glycosyltransferases in the form
of PimA, PimB and PimC, which are implicated in the
initial steps of lipoglycan formation (Schaeffer et al.,
1999; Kordulakova et al., 2002; Kremer et al., 2002).
EmbC (Zhang et al., 2003) and Rv1635c (Dinadayala
et al., 2006) have been shown to construct the bulk of
arabinan and mannose capping of LAM respectively. The
proteins participating in the intermediate steps of
LM/LAM biosynthesis remain largely unresolved, apart
Fig. 7. a(1→6)-Mannosyltransferase activity in membranes prepared from C. glutamicum, C. glutamicumDmptA, C. glutamicumDmptA
pVWEx-Cg-mptA and C. glutamicumDmptA pVWEx-Mt-mptA.
A. Biosynthetic reaction scheme of products formed in the a(1→6)-mannosyltransferase assay utilizing a-D-Manp-(1→6)-a-D-Manp-O-C8 and
C50-PP[
14C]M.
B. a(1→6)-Mannosyltransferase activity determined using the synthetic a-D-Manp-(1→6)-a-D-Manp-O-C8 neoglycolipid acceptor in a cell-free
assay using 1 mg of membrane protein as described previously (Brown et al., 2001). The products of the assay were re-suspended in
n-butanol before scintillation counting. The incorporation of [
14C]Manp was determined by subtracting counts present in control assays
(incubations in the absence of acceptor), which were typically less than 100 cpm per assay. The remaining labelled material was subjected to
TLC using silica gel plates (5735 silca gel 60F254, Merck) developed in CHCl3/CH3OH/H2O/NH4OH (65:25:3.6:0.5, v/v/v/v) and the products
visualized by phosphorimaging (Kodak K Screen). The results represent triplicate assays in two independent experiments.
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a(1→2) branching in LM (Kaur et al., 2006). However,
the linear a(1→6) backbone of LM and LAM, which
serves as a core for higher polysaccharide elaboration in
the form of a(1→2) branching and arabinosylation, until
this report has remained unidentiﬁed.
The GT-C family of glycosyltransferases are well dis-
persed throughout the eukaryotes but are limited within
the prokaryotes to the supragenic taxon of the Actinomyc-
etales (Liu and Mushegian, 2003). However, due to the
nature of these proteins, very little is understood regard-
ing their protein fold, mechanism of catalysis and bioin-
formatic signatures (Berg et al., 2007). In this study, we
sought to characterize the role of a putative glycosyltrans-
ferase (Rv2174) belonging to the GT-C superfamily of
glycosyltransferases (Liu and Mushegian, 2003) by virtue
of genomic deletion of its orthologue NCgl2093 in
C. glutamicum. As LAM is a vital component of the
M. tuberculosis cell wall and Rv2174 is predicted to be an
essential gene (Sassetti et al., 2003), we utilized
C. glutamicum as a ‘proof of principle’model to dissect the
Corynebacteriaceae lipoglycan biosynthetic pathway,
analogous to our previous investigations regarding ara-
binogalactan assembly (Alderwick et al., 2006; Seidel
et al., 2007a). It is not entirely clear why essential ortholo-
gous genes from M. tuberculosis can be deleted from
C. glutamicum, such as emb (Alderwick et al., 2005), aftA
(Alderwick et al., 2006), aftB (Seidel et al., 2007a) and
mptA (this study). Although the structures are similar, in
terms of AG and LM/LAM, a possible explanation for this
paradox may be related to their respective growth rates.
This seems entirely plausible when we consider emb
mutants are readily generated in the fast-growing myco-
bacterial strain M. smegmatis, which are otherwise unat-
tainable in slow growing M. tuberculosis. We present
MptAas a PPM-dependent a(1→6) mannosyltransferase,
involved in latter stages of LM biosynthesis, which then
serves as a template for further a(1→2) branching by
other a-mannosyltransferases, presumably Rv2181 (Kaur
et al., 2006).
Our initial investigation of the extractable PIMs from
C. glutamicumDmptA highlighted no apparent change in
the proﬁles compared with those from C. glutamicum
(Fig. S3), which indicated that MptA was not involved in
PIM biosynthesis. This was not unsurprising, as PIM bio-
synthesis is completely unique to enzymes belonging to
the GT-A/B glycosyltransferase family, which utilize
GDP-Manp as a substrate (Liu and Mushegian, 2003).
However, examination of lipoglycans from C. gluta-
micumDmptA afforded a complete loss of Cg-LM and
Cg-LAM, and the appearance of a new smaller product
(Cg-t-LM) as observed on a SDS-PAGE gel (Fig. 3).
Interestingly, complementation of C. glutamicumDmptA
with a plasmid encoding Cg-mptA and Mt-mptA, restored
the lipoglycan proﬁles to that of wild-type C. glutamicum
(Fig. 3). Taken together our exhaustive chemical analy-
sis of Cg-t-LM indicates that Cg-t-LM in C. glutamicum-
DmptA occurs as a result of inactivation of a core
a(1→6) mannosyltransferase, presumably involved in
assembly of the distal portion of LM, thereby rendering a
substrate possessing reduced sites for branching. The
enzymatic activity of NCgl2093 and Rv2174 were con-
ﬁrmed as bona ﬁde a(1→6) mannosyltransferase in a
speciﬁc neoglycolipid acceptor assay (Brown et al.,
2001).
The apparent residual glycosyltransferase activity in
membranes extracted from C. glutamicumDmptA in the
neoglycolipid assay could be attributed to another PPM-
dependent GT-C mannosyltransferase, but one which
has a lower efficacy for the particular acceptor used
herein. This situation is entirely plausible as our evi-
dence suggests that there are at least two a(1→6) man-
nosyltransferases, which utilize PPM as a substrate for
glycosyl transfer, inferring that both belong to the GT-C
family of glycosyltransferases (Liu and Mushegian,
2003) and are therefore involved in LM-backbone syn-
thesis. Indeed, inspection of the NMR and glycosyl
linkage data hints that MptA is involved in the latter
stages of a(1→6) backbone synthesis, which is likely to
be more highly elaborated with a(1→2) mannose resi-
dues compared with the PI-end of the polysaccharide
which contains less branching.
This system of polysaccharide biosynthesis is mirrored
in the assembly of Corynebacteriaceae arabinogalactan,
for which several glycosyltransferases are involved in
priming, extension and termination of arabinan biosynthe-
sis, in the form ofAftA,AftB and the Emb proteins (Escuyer
et al., 2001; Alderwick et al., 2005; 2006; Seidel et al.,
2007a). It may be argued that in order for the complete
biosynthesis of Cg-LAM, a fully functional molecule of
Cg-LM must be assembled to serve as a precursor for
Cg-LAM-speciﬁcarabinosyltransferases.Furthermore,the
biosynthesis of LM and LAM is likely to occur in discrete
steps, with each glycosyltransferase recognizing a previ-
ously synthesized acceptor molecule which is suitably
‘primed’ for the next step of molecular assembly (Fig. 8).
Herein, we are proposing a biosynthetic pathway that
involves MptAas an a(1→6) mannosyltransferase respon-
sible for the latter stages of LM-backbone biosynthesis,
and sheds further light on the complexities of Corynebac-
teriaceae cell wall biosynthesis as a potential drug target.
Experimental procedures
Bacterial strains and growth conditions
Corynebacterium glutamicum ATCC 13032 (the wild-type
strain, and referred to for the remainder of the text as
C. glutamicum) and Escherichia coli DH5amcr were grown
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respectively. The recombinant strains generated in this study
were grown on complex BHI medium (Difco), and the salt
medium CGXII used for C. glutamicum as described
(Eggeling and Bott, 2005). Kanamycin and ampicillin were
used at a concentration of 50 mgm l
-1. Samples for lipid analy-
ses were prepared by harvesting cells at an optical density
(OD) of 10–15, followed by a saline wash and freeze drying.
M. tuberculosis H37Rv DNAwas obtained from Dr J.T. Belisle
at the NIH Tuberculosis Research Materials and Vaccine
Testing Contract at Colorado State University. All other
chemicals were of reagent grade and obtained from Sigma-
Aldrich.
Construction of plasmids and strains
In order to enable deletion of the gene with the locus tag
C. glutamicum NCgl2093 (Cg-mptA) the primer pair P1,
CGCTTCTAGACAACGCGCTGATAAGCAATCTCC (all pri-
mers given in 5′ to 3′ direction) and P2rev, CCCATCCAC
TAAACTTAAACACGTTGAAAAAGTGTCATACGCG, were
used with start codon in bold and restriction endonuclease
sites underlined to generate a 288 bp fragment upstream of
NCgl2093. Similarly the pair P3, TGTTTAAGTTTAGTG
GATGGGACTGACCCTGCAACAAC, and P4rev, GCGG
GAATTCGAAGGAAAACACCAACCGTTTCATC, was used
to generate a 340 bp downstream fragment. Using both iso-
Fig. 8. Proposed biosynthetic of lipoglycans
in Corynebacterianeae.A c 1PIM2 represents
the initiation point for further lipoglycan
assembly leading to Cg-t-LM, LM and LAM.
n denotes residues of unknown numbers,
whereas x represents residues ranging from
0t o2 .
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and P4rev to generate a 628 bp fragment which was cloned
into EcoRI–XbaI-cleaved pK19mobsacB (Schafer et al.,
1994) resulting in pK19mobsacBDmptA.
To enable plasmid encoded expression of C. glutamicum
NCgl2093 (Cg-mptA), the gene was ampliﬁed using the
primer pairs 2093for, CGCGTCATATGACACTTTTTCAAC
GTTTAACCAAC, and 2093rev, GTAATGGATCCTAGGAA
ACGGTATGCGGGGAG, with start and stop codons in bold
and restriction endonuclease sites underlined. The resulting
fragment was cloned into pGEM-T, excised as an NdeI–
BamHI fragment and inserted into NdeI–BamHI-cleaved
pET16b to result in pET16b-NCgl 2093 for expression studies
in E. coli. For expression in C. glutamicum the primer pair
2093rev together with 2093RBSfor, GCGCGGTTAACAGG
GAGATATAGATGACACTTTTTCAACGTTTAAC, was used.
The resulting fragment was cloned into pGEM-T, excised as
an HpaI–SpeI fragment and cloned into the E. coli–C.
glutamicum shuttle vector pVWEx resulting in pVWEx-Cg-
mptA.
To clone Rv2174 of M. tuberculosis (Mt-mptA) the primer
pairs Rv2174for, CATCTACATATGACTACTCCGAGCCAT
GCTCCAGC, and Rv2174rev, CAGTGAGATCTCTATGGCG
TATTGACCACCG, were used. The ampliﬁcate was cloned
into pGEM-T as above and inserted into pET16b resulting in
pET16b-Rv2174 for expression studies in E. coli. For expres-
sion in C. glutamicum the primer pair 2174rev together with
2174RBSfor, CACTAGTTAACAGGGAGATATAGATGACTA
CTCCGAGCCATG, was used. The resulting fragment was
cloned as above into pGEM-T and subcloned resulting in
pVWEx-Mt-mptA. All plasmids used were conﬁrmed by
sequencing for integrity.
For the chromosomal deletion of Cg-mptA, plasmid
pK19mobsacBDmptA was used, taking advantage of the
kanamycin resistance gene aph, to select for plasmid inte-
gration in the ﬁrst round of homologuous recombination and
the sucrose gene sacB, to select for loss of vector in the
second round of homologuous recombination (Jager et al.,
1992). The successful deletion in the resulting strain
C. glutamicumDmptA was veriﬁed by use of two different
primer pairs. The ampliﬁcation with primers CGGCCGCTTA
CACGATTGCGC (P1) and CGCAGAAATACCCTAAAGAT
TCTCCATTAGAGC (P4), is shown in Fig. 2C, giving the
expected sizes of 2505 bp in the wild type and 1050 bp in
the deletion mutant. Plasmid pVWEx-Cg-mptA and pVWEx-
Mt-mptA were introduced into C. glutamicumDmptA by
electroporation with selection to kanamycin resistance
(25 mgm l
-1).
Lipid extraction and analysis
Polar lipids and apolar lipids were extracted as described
previously (Tatituri et al., 2007). Brieﬂy, 6 g of dry
C. glutamicum cells were treated in 220 ml of methanolic
saline (20 ml of 0.3% NaCl and 200 ml of CH3OH) and
220 ml of petroleum ether for 2 h. The suspension was
centrifuged and the upper layer containing apolar lipids was
separated. An additional 220 ml of petroleum ether was
added, mixed and centrifuged as described above. The two
upper petroleum ether fractions were combined and dried.
For polar lipids, 260 ml of CHCl3/CH3OH/0.3% NaCl (9:10:3,
v/v/v) was added to the lower aqueous phase and stirred for
4 h. The mixture was ﬁltered and the ﬁlter cake re-extracted
twice with 85 ml of CHCl3/CH3OH/0.3% NaCl (5:10:4, v/v/v).
Equal amounts of CHCl3 and 0.3% NaCl (145 ml each)
were added to the combined ﬁltrates and stirred for 1 h.
The mixture was allowed to settle, and the lower layer
containing the polar lipids recovered and dried. The polar
lipid extract was examined by two-dimensional TLC on
aluminum-backed plates of silica gel 60F254 (Merck 5554),
using CHCl3/CH3OH/H2O (65:25:4, v/v/v) in the ﬁrst direction
and CHCl3/CH3COOH/CH3OH/H2O (40:25:3:6, v/v/v/v) in the
second direction. Glycolipids were visualized by either
spraying plates with a-naphthol/sulphuric acid or 5% etha-
nolic molybdophosphoric acid followed by gentle charring of
plates. Identiﬁcation of phospholipids was carried out using
the Dittmer and Lester reagent as described in Tatituri et al.
(2007).
Extraction and puriﬁcation of lipoglycans
Lipoglycans were extracted from previously delipidated
cells (lipid extraction and analysis) as previously described
(Nigou et al., 1997; Ludwiczak et al., 2002). Brieﬂy, cells were
broken by sonication (MSE Soniprep 150, 12 micron ampli-
tude, 60 s ON, 90 s OFF for 10 cycles, on ice) and the cell
debris reﬂuxed ﬁve times with 50% C2H5OH at 68°C, for 12 h
intervals. The cell debris was removed by centrifugation and
the supernatant containing lipoglycans, neutral glycans and
proteins dried. This dried extract was then treated with hot
phenol-H2O. The aqueous phase was dialysed against H2O
(5 l) using a 1500 MWCO membrane (Spectrapore) and
dried, followed by extensive treatments with a-amylase,
DNase, RNase chymotrypsin and trypsin. The fraction was
dialysed once again in H2O (5 l) to remove residual impurities
and enzymes.
The crude lipoglycan extract was dried and re-suspended
in buffer A (50 mM ammonium acetate and 15% propan-1-
ol) and subjected to Octyl Sepharose CL-4B HIC
(2.5 cm ¥ 50 cm) (Leopold and Fischer, 1993). The column
was washed initially with 4 column volumes of buffer A to
ensure removal of neutral glycans followed by buffer B
(50 mM ammonium acetate and 50% propan-1-ol). The
eluent was collected and concentrated to approximately
1 ml and precipitated using 5 ml of C2H5OH. The sample
was dried using a Savant Speedvac and then re-suspended
in buffer C [0.2 M NaCl, 0.25% sodium deoxycholate (w/v),
1 mM EDTA and 10 mM Tris-HCl, pH 8] to a ﬁnal concen-
tration of 200 mg ml
-1. The sample was gently mixed and
left to incubate for 48 h at room temperature. The sample
was then loaded onto a 200 ml Sephacryl S-200 column
previously equilibrated with buffer C. The sample was
eluted with 400 ml of buffer C at a ﬂow rate of 3 ml h
-1,
collecting 1.5 ml fractions. The fractions were monitored by
SDS-PAGE using either a silver stain utilizing periodic acid
and silver nitrate (Hunter et al., 1986) or a Pro-Q emerald
glycoprotein stain (Invitrogen) and individual fractions
pooled and dialysed extensively against buffer D (10 mM
Tris-HCl, pH 8, 0.2 M NaCl, 1 mM EDTA) using a 1500
MWCO membrane (Spectrapore) for 72 h with frequent
changes of buffer. The samples were further dialysed
against deionized water for 48 h using a 1500 MWCO mem-
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philized and stored at -20°C.
Glycosyl compositional and linkage analysis
Lipoglycans were hydrolysed using 2 M triﬂuoroacetic acid,
reduced with NaB
2H4, and the resultant alditols per-O-
acetylated before examination by GC (Tatituri et al., 2007).
Glycosyl linkage analyses were performed as described
previously (Tatituri et al., 2007). Brieﬂy, lipoglycan samples
were per-O-methylated using dimethyl sulphinyl carbanion,
hydrolysed using 2 M triﬂuoroacetic acid, reduced using
NaB
2H4 and per-O-acetylated. The resulting per-O-
methylated alditol acetates were solubilized in CHCl3
before analysis by gas chromatography/mass spectrometry
(GC/MS) (Tatituri et al., 2007). GC analysis was performed
using a Thermoquest Trace GC 2000. Samples were injected
in the splitless mode. The column used was a DB225
(Supelco). The oven was programmed to hold at an isother-
mal temperature of 275°C for a run time of 15 min. GC/MS
was carried out on a Finnigan Polaris/GCQ PlusTM. The
column used was a BPX5 (Supleco). Injector temperature
was set at 50°C, held for 1 min and then increased to 110°C
at 20°C min
-1. The oven was held at 110°C then ramped to
290°C at 8°C min
-1 and held for 5 min to ensure all the
products had eluted from the column. All the data were col-
lected and analysed using Xcaliber (v.1.2) software.
MALDI-TOF-MS analyses
The matrix used was 2,5-dihydroxybenzoic acid at a concen-
tration of 10 mg ml
-1, in a mixture of water/ethanol (1:1, v/v),
0.1% triﬂuoroacetic acid. LM samples (0.5 ml) at a concentra-
tion of 10 mg ml
-1 were mixed with 0.5 ml of the matrix solution.
Analyses were performed on a Voyager DE-STR MALDI-TOF
instrument (PerSeptive Biosystems, Framingham, MA) using
linear mode detection. Mass spectra were recorded in the
negative mode using a 300 ns time delay with a grid voltage
of 80% of full accelerating voltage (25 kV) and a guide wire
voltage of 0.15%. The mass spectra were mass assigned
using external calibration.
NMR spectroscopy
Nuclear magnetic resonance spectra of LM samples were
recorded on a Bruker DMX-500 equipped with a double reso-
nance (1H/X)-BBi z-gradient probe head. All samples were
exchanged in D2O (D, 99.97% from Euriso-top, Saint-Aubin,
France), with intermediate lyophilization, and then dissolved
in 0.5 ml of D2O and analysed at 313K. The
1H and
13C NMR
chemical shifts were referenced relative to internal acetone at
2.225 and 34.00 p.p.m. respectively. All the details concern-
ing NMR sequences used and experimental procedures were
described previously (Gilleron et al., 1999; 2000).
In vitro analysis of a(1,6) mannosyltransferase activity
Corynebacterium glutamicum, C. glutamicumDmptA, C. glu-
tamicumDmptA pVWEx-Cg-mptA and C. glutamicumDmptA
pVWEx-Mt-mptA were cultured to the mid-logarithmic growth
phase in 1 l of BHIS medium supplemented with kanamycin
and 0.2 mM IPTG where appropriate. Cells were harvested
by centrifugation, re-suspended in 20 ml of buffer E (50 mM
MOPS pH 7.9, 5 mM 2-mercaptoethanol and 5 mM MgCl2)
and lysed immediately by sonication (60 s ON, 90 s OFF for
a total of 10 cycles). The lysate was clariﬁed by centrifugation
at 27 000 g (4°C, 30 min) and membranes were deposited by
centrifugation of the supernatant at 105 000 g (4°C, 90 min).
The membranes were re-suspended in buffer E to a ﬁnal
protein concentration of 10–15 mg ml
-1. The neoglyco-
lipid acceptor a-D-Manp-(1→6)-a-D-Manp-O-C8 (stored in
C2H5OH) and C50-PP[
14C]M [stored in CHCl3/CH3OH, 2:1, v/v,
and prepared as described in Gurcha et al. (2002)] were
separated into aliquots into 1.5 ml eppendorf tubes to a ﬁnal
concentration of 2 mM and 0.25 mCi (0.305 Ci mmol
-1),
respectively, and dried under nitrogen. IgePal CA-630 (Sigma
Aldrich) was added (0.1%, v/v) with appropriate amounts of
buffer E (ﬁnal volume 80 ml). Tubes were sonicated for 15 min
to re-suspend the lipid-linked components and then mixed
thoroughly with the remaining assay components, which
included 1 mM ATP, 1 mM NADP, and membrane protein
(1 mg) from either C. glutamicum, C. glutamicumDmptA,
C. glutamicumDmptA pVWEx-Cg-mptA or C. glutami-
cumDmptA pVWEx-Mt-mptA. Assays were initiated and incu-
bated at 37°C for 1 h. The reaction was quenched with the
addition of 533 ml of CHCl3/CH3OH (1:1, v/v).After mixing and
centrifugation at 27 000 g for 15 min at 4°C, the supernatant
was removed and dried under nitrogen. The residue was then
re-suspended in 700 mlo fC 2H5OH/H2O (1:1, v/v) and loaded
onto a 1 ml SepPak strong anion exchange cartridge
(Supleco) pre-equilibrated with C2H5OH/H2O (1:1, v/v). The
column was washed with 2 ml of C2H5OH, and the eluate
collected, dried and partitioned between the two phases
arising from a mixture of n-butanol (3 ml) and water (3 ml).
The resulting organic phase was recovered after centrifuga-
tion at 3500 g, and the aqueous phase was again extracted
twice with 3 ml of water-saturated butanol. The pooled
extracts were back-washed twice with n-butanol saturated
water (3 ml). The n-butanol fraction was dried and
re-suspended in 200 mlo fn-butanol. The extracted radiola-
belled material was quantiﬁed by liquid scintillation counting
using 10% of the labelled material and 5 ml of EcoScintA
(National Diagnostics, Atlanta, GA). The incorporation of
[
14C]Manp was determined by subtracting counts present in
control assays (incubations in the absence of acceptor),
which were typically less than 100 cpm per assay. The
remaining labelled material was subjected to TLC using silica
gel plates (5735 silca gel 60F254, Merck) developed in CHCl3/
CH3OH/H2O/NH4OH (65:25:3.6:0.5, v/v/v/v) and the products
visualized by phosphorimaging (Kodak K Screen).
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